MG
Marex Group Portfolio holdings
AUM
$5.26B
This Quarter Return
+11.72%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.26B
AUM Growth
–
Cap. Flow
+$5.26B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
49.25%
Holding
531
New
516
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
$760M |
| 2 |
Mastercard
MA
|
$437M |
| 3 |
Booking.com
BKNG
|
$375M |
| 4 |
Eli Lilly
LLY
|
$222M |
| 5 |
Tesla
TSLA
|
$173M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 34.04% |
| 2 | Financials | 19.17% |
| 3 | Consumer Discretionary | 16.81% |
| 4 | Healthcare | 14.34% |
| 5 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
451
DELISTED
Golden Ocean Group
GOGL
| $82.7K | ﹤0.01% |
+11,293
| New | +$82.7K |
|
452
Biomea Fusion
BMEA
$114M
| $81K | ﹤0.01% |
+45,000
| New | +$81K |
|
|
BBBY
453
Bed Bath & Beyond, Inc.
BBBY
$567M
| $79.5K | ﹤0.01% |
+11,554
| New | +$79.5K |
|
454
Compass
COMP
$5.07B
| $75.9K | ﹤0.01% |
+12,085
| New | +$75.9K |
|
455
QuantumScape
QS
$4.44B
| $75.5K | ﹤0.01% |
+11,241
| New | +$75.5K |
|
456
Jasper Therapeutics
JSPR
$44.2M
| $73.8K | ﹤0.01% |
+13,300
| New | +$73.8K |
|
457
Payoneer
PAYO
$2.4B
| $72.3K | ﹤0.01% |
+10,554
| New | +$72.3K |
|
|
MCTR
458
CTRL Group Limited Ordinary Shares
MCTR
$26M
| $70.5K | ﹤0.01% |
+25,000
| New | +$70.5K |
|
459
AbCellera Biologics
ABCL
$1.26B
| $68.6K | ﹤0.01% |
+20,000
| New | +$68.6K |
|
460
Fortuna Silver Mines
FSM
$2.35B
| $68.2K | ﹤0.01% |
+10,428
| New | +$68.2K |
|
461
TMC The Metals Company
TMC
$2.08B
| $66K | ﹤0.01% |
+10,000
| New | +$66K |
|
|
IMMP
462
Immutep
IMMP
$242M
| $64.5K | ﹤0.01% |
+39,380
| New | +$64.5K |
|
|
VALN
463
Valneva
VALN
$743M
| $64.1K | ﹤0.01% |
+11,300
| New | +$64.1K |
|
|
BMNR
464
BitMine Immersion Technologies, Inc.
BMNR
$7.29B
| $63.2K | ﹤0.01% |
+13,705
| New | +$63.2K |
|
465
IO Biotech
IOBT
$128M
| $62.6K | ﹤0.01% |
+45,000
| New | +$62.6K |
|
466
Compass Therapeutics
CMPX
$590M
| $61.4K | ﹤0.01% |
+23,600
| New | +$61.4K |
|
|
RAY
467
Raytech Holding Ltd
RAY
$25.4M
| $59.9K | ﹤0.01% |
+51,216
| New | +$59.9K |
|
|
LHSW
468
Lianhe Sowell International Group Ltd Ordinary Shares
LHSW
$108M
| $57.5K | ﹤0.01% |
+33,815
| New | +$57.5K |
|
469
Rocket Pharmaceuticals
RCKT
$354M
| $55.1K | ﹤0.01% |
+22,500
| New | +$55.1K |
|
470
Asset Entities
ASST
$75.5M
| $54K | ﹤0.01% |
+14,400
| New | +$54K |
|
|
NAMI
471
Jinxin Technology Holding Company American Depositary Shares
NAMI
$73.8M
| $52.8K | ﹤0.01% |
+50,798
| New | +$52.8K |
|
|
BLIV
472
BeLive Holdings Ordinary Share
BLIV
$39.9M
| $47.6K | ﹤0.01% |
+15,060
| New | +$47.6K |
|
473
Ambev
ABEV
$34.8B
| $47.6K | ﹤0.01% |
+19,740
| New | +$47.6K |
|
|
ADAG
474
Adagene
ADAG
$104M
| $46.8K | ﹤0.01% |
+24,000
| New | +$46.8K |
|
475
La Rosa Holding
LRHC
$8.09M
| $46.8K | ﹤0.01% |
+4,483
| New | +$46.8K |
|